Sex differences in tuberculosis infection and disease among people with HIV
- PMID: 39453876
- PMCID: PMC11717608
- DOI: 10.1097/QAD.0000000000004045
Sex differences in tuberculosis infection and disease among people with HIV
Abstract
Objectives: Worldwide, adult men experience an excess burden of tuberculosis (TB) disease compared with women, but few studies have examined sex differences in TB among people with HIV. In this study, we aimed to investigate sex differences in TB infection and disease among people with HIV in Rio de Janeiro, Brazil.
Design: Analysis of data from a randomized controlled trial and retrospective cohort study.
Methods: We analyzed data from two studies conducted between 2005 and 2017. The THRio Study (2005-2012) evaluated increasing tuberculin skin testing (TST) and TB preventive therapy (TPT), and Universal ART in Rio study (UnivART; 2010-2017) was a virtual cohort study of people with HIV and TB with data from four national electronic registries.
Results: Among 4606 people with HIV in THRio, 2992 (65.0%) had a TST placed and read, of whom 312 of 1865 (17%) males and 203 of 1127 (18%) females ( P = 0.37) had prevalent TB infection. TB disease incidence was higher among males compared with females overall [IRR 1.33, 95% confidence interval (95% CI) 1.04-1.69], among males compared with females who did not receive TPT [incidence rate ratios (IRR) 1.30, 95% CI 1.01-1.67], and among males compared with females on ART (IRR 1.64, 95% CI 1.17-2.29). Among 54 957 people with HIV in UnivART, TB disease incidence rates were higher among males than females overall (IRR 1.28, 95% CI 1.18-1.39), among males compared with females on ART (IRR 1.58, 95% CI 1.40-1.77), and among males compared with females not on ART (IRR 1.11, 95% CI 0.99-1.25).
Conclusion: In this medium TB and HIV burden setting, TB disease incidence was higher among males than females with HIV, despite similar prevalence of TB infection.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
These studies were supported by the Bill & Melinda Gates Foundation (19790.01 to the Consortium to Respond Effectively to the AIDS-Tuberculosis Epidemic); the Johns Hopkins Center for AIDS Research (P30 AI094189 to REC); the Johns Hopkins Tuberculosis Research Advancement Center (P30 AI168436 to REC) and the Johns Hopkins HIV Epidemiology and Prevention Sciences Training Program (T32 AI102623 to LHC). The funding organizations had no role in the design, collection, analysis, or interpretation of data. Earlier versions of this analysis were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in 2022 and the Union World Conference on Lung Health in 2023. The authors declare no conflicts of interest.
Similar articles
-
Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.Clin Infect Dis. 2015 Feb 15;60(4):639-45. doi: 10.1093/cid/ciu849. Epub 2014 Nov 2. Clin Infect Dis. 2015. PMID: 25365974 Free PMC article.
-
Incidence and risk factors for tuberculosis at a rural HIV clinic in Uganda, 2012-2019; A retrospective cohort study.BMC Public Health. 2025 May 22;25(1):1882. doi: 10.1186/s12889-025-23090-8. BMC Public Health. 2025. PMID: 40405106 Free PMC article.
-
CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.AIDS. 2020 Jan 1;34(1):139-147. doi: 10.1097/QAD.0000000000002398. AIDS. 2020. PMID: 31634189 Free PMC article. Clinical Trial.
-
Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):98-101. doi: 10.1097/QAI.0000000000000247. J Acquir Immune Defic Syndr. 2014. PMID: 24933097 Free PMC article.
-
Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.PLoS Med. 2021 Sep 14;18(9):e1003712. doi: 10.1371/journal.pmed.1003712. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34520463 Free PMC article.
Cited by
-
Impact of a TB Team on TB Outcomes: A 2016-2024 Pre-Post Study From a Referral Center in Southern Italy.Open Forum Infect Dis. 2025 Apr 28;12(5):ofaf258. doi: 10.1093/ofid/ofaf258. eCollection 2025 May. Open Forum Infect Dis. 2025. PMID: 40376187 Free PMC article.
-
Trends in prevalent TB among persons enrolling for HIV care before and after 'Test and Treat' across East-Africa.IJTLD Open. 2025 Jun 13;2(6):359-365. doi: 10.5588/ijtldopen.24.0687. eCollection 2025 Jun. IJTLD Open. 2025. PMID: 40530380 Free PMC article.
References
-
- World Health Organization. Global Tuberculosis Report 2023. Geneva: ; 2023.
-
- Chidambaram V, Tun NL, Majella MG, Ruelas Castillo J, Ayeh SK, Kumar A, et al. Male Sex Is Associated With Worse Microbiological and Clinical Outcomes Following Tuberculosis Treatment: A Retrospective Cohort Study, a Systematic Review of the Literature, and Meta-analysis. Clin Infect Dis 2021; 73:1580–1588. - PMC - PubMed
-
- Borgdorff MW, Nagelkerke NJ, Dye C, Nunn P. Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. Int J Tuberc Lung Dis 2000; 4:123–132. - PubMed
-
- World Health Organization. National tuberculosis prevalence surveys, 2007–2016. Geneva: ; 2021.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical